Primary Analysis of the SYMPATICO trial in Mantle Cell Lymphoma

Focusing on mantle cell lymphoma, Lori A. Leslie, MD, reviews the primary analysis of the SYMPATICO trial investigating ibrutinib-venetoclax combination therapy.

Related Keywords

Lori Leslie ,Jamesk Mccloskey ,Gloria Leslie ,Hackensack University Medical Center ,John Theurer Cancer Center ,Research Programs ,Peer Exchange ,Hackensack University Medical ,Associate Professor ,Indolent Lymphoma ,While Bruton ,Lymphoma ,Mash 2023 ,Sympatico Study ,Sympatico Trial ,Mantle Cell Lymphoma ,Btk Inhibitors ,Venetoclax ,Ibrutinib ,Combination Therapy ,